Accueil - CRCL-Présentation d’antigène et antigènes tumoraux non conventionnels

Audrey Page, Nicolas Chuvin, Jenny Valladeau-Guilemond, Stéphane Depil. Development of NK cell-based cancer immunotherapies through receptor engineering. Cellular and molecular immunology, 2024, 21, pp.315 - 331. ⟨10.1038/s41423-024-01145-x⟩. ⟨hal-04567993⟩
Benjamin Ducarouge, Anna-Rita Redavid, Camille Victoor, Ruxanda Chira, Aurélien Fonseca, et al.. Netrin-1 blockade inhibits tumor associated Myeloid-derived suppressor cells, cancer stemness and alleviates resistance to chemotherapy and immune checkpoint inhibitor. Cell Death and Differentiation, 2023, 30 (10), pp.2201-2212. ⟨10.1038/s41418-023-01209-x⟩. ⟨hal-04253805⟩
Estelle Baulu, Célia Gardet, Nicolas Chuvin, Stéphane Depil. TCR-engineered T cell therapy in solid tumors: State of the art and perspectives. Science Advances , 2023, 9 (7), ⟨10.1126/sciadv.adf3700⟩. ⟨hal-04115921⟩
Felix Bayerl, David A Bejarano, Giulia Bertacchi, Anne‐claire Doffin, Elisa Gobbini, et al.. Guidelines for visualization and analysis of DC in tissues using multiparameter fluorescence microscopy imaging methods. European Journal of Immunology, 2023, 53 (11), pp.2249923. ⟨10.1002/eji.202249923⟩. ⟨hal-04477856⟩
Anaïs Eberhardt, Elena Blanc, Valentin Picant, Vincent Alcazer, Yamila Rocca, et al.. IL-33 drives polyfunctionality and antitumor activity of a unique ST2+ NK cell population. 2022. ⟨hal-03877982⟩
Vincent Alcazer, Paola Bonaventura, Laurie Tonon, Emilie Michel, Virginie Mutez, et al.. HERVs characterize normal and leukemia stem cells and represent a source of shared epitopes for cancer immunotherapy. American Journal of Hematology, 2022, 97 (9), pp.1200-1214. ⟨10.1002/ajh.26647⟩. ⟨hal-03855460⟩

Derniers manuscrits de l'équipe

Chiffres clés